ALL BLOG CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. ANY REFERENCE TO OR MENTION OF INDIVIDUAL STOCKS, INDEXES, OR OTHER SECURITIES ARE NOT RECOMMENDATIONS AND ARE SPECIFICALLY NOT REFERENCED AS PAST RECOMMENDATIONS OF PATTON WEALTH ADVISORS. ALL GRAPHS, CHARTS, AND TABLES ARE PROVIDED FOR ILLUSTRATION PURPOSES ONLY. EXPRESSIONS OF OPINION ARE ALSO NOT RECOMMENDATIONS AND ARE SUBJECT TO CHANGE WITHOUT NOTICE IN REACTION TO SHIFTING MARKET, ECONOMIC, OR POLITICAL CONDITIONS. IT IS COMMON FOR US TO USE A FUND AS A PROXY FOR AN INDEX OR ASSET CLASS. FOR MORE DETAILS SEE OUR FULL DISCLOSURE HERE.
Week 2 Market Recap
Markets were mixed in the second week of the year with large U.S. stocks (the S&P 500) down fractionally while small U.S. stocks continued to inch higher by 0.4%. International stocks continued to meaningfully outpace U.S. stocks in the second week with gains of nearly 1% for developed countries and more than 2% for emerging countries. Real estate, or publicly traded REITs were the loser this week down more than 2%.
Notable Market Headlines
- Earnings Season Begins – the quarterly earnings season kicked off with three of the largest financial institutions reporting earnings: J.P. Morgan, Bank of America, and Wells Fargo. These have been some of the Trump Rally leaders
- Dow Remains Below 20,000 – on Friday it got within 50 points but retreated from there to close at 19,885.
- 10-Year Government Bond Yield at 2.397% – continuing to ease off their 2.6% December high but still well above Summer 2016 lows below 1.4%.
Top 10 Performers – Summary
- 4 of the Top 10 are healthcare stocks
- Gained an average of 8.5%
- 2 have no earnings and the other 8 have an average price/earnings (P/E) ratio of 77...more than double the market’s average suggesting that earnings aren’t everything when it comes to predicting stock performance.
- Illumina, Inc.
- High-tech healthcare company in the business of sequencing and genetic analysis
- Announced partnership with Royal Philips that should expand both companies market opportunities
- The stock was up 15% for the week and 27% year-to-date after being DOWN -33% in 2016
- Zimmer Biomet Holdings
- Healthcare company making a wide range of related products
- Announced stronger than expected 4th quarter sales
- Stock rallied 9.8%
- Earnings declined more than 80% in 2015 and have rebounded in 2016
Bottom 10 Performers – Summary
- 3 of the 10 worst performers were healthcare stocks. Note that 4 of the top 10 winners were also healthcare stocks…this is somewhat unusual behavior.
- o Endo International was the biggest loser as investors continue to be concerned about the company’s revenue and earnings outlook.
- The worst performs have an average dividend yield of 2.98% or more than 50% higher than the average S&P 500 stock. Higher dividend yielding stocks have been performing better than lower dividend yield stocks for the past few years. Last week is, at least, a short-term reversal of that trend.
Economic Indicator - Reported
December Retail Sales: +0.6%. Excluding cars and gasoline, sales were flat which certainly did not make for a good holiday season for the country’s retails.
As one would expect, e-commerce sales are growing at a much faster pace than total retail sales:
Economic Indicators – Upcoming
- Consumer Price Index (inflation) – estimates range from +0.2% - +0.5%.
- Housing Starts – estimates range from 1.100 - 1.275 million starts
The Dow Jones Industrial Index consisting of 30 stocks is up 1,553 points since the election. Goldman Sachs, 1 of the 30 stocks, has accounted for how many of those 1,553 points?
427. In other words, 1 of the 30 stocks in the Dow Jones index is responsible for 27% of its total gain since the election. This is due to, of course, Goldman Sachs stock gaining over that time but it is more about the way in which the Dow Jones index is calculated…higher priced stocks have more impact on the Dow’s performance.
The information provided here is for general informational purposes only and should not be considered an individualized recommendation or personalized investment advice. Any specific securities or investment strategies mentioned here may not be suitable for everyone. Each investor needs to review an investment strategy for his or her own situation before making any investment decision including whether to retain an investment adviser.
All expressions of opinion are subject to change without notice in reaction to shifting market, economic or political conditions. Data contained herein from third party providers is obtained from what are considered reliable sources. However, its accuracy, completeness or reliability cannot be guaranteed. This content was created as of the specific date indicated and reflects the author’s views as of that date. Supporting documentation for any claims or statistical information is available upon request.
Past performance is no guarantee of future results. Any comments about the performance of securities, markets, or indexes and any opinions presented are not to be viewed as indicators of future performance.
Investing involves risk including loss of principal.
Indexes are unmanaged, do not incur management fees, costs and expenses, and cannot be invested in directly. For more information on specific indexes please see full disclosure here.
Any charts, tables, forecasts, etc. contained herein are for illustrative purposes only, may be based upon proprietary research, and are developed through analysis of historical public data.
All corporate names shown above are for illustrative purposes only and are NOT recommendations.
International investments involve additional risks, which include differences in financial accounting standards, currency fluctuations, geopolitical risk, foreign taxes and regulations, and the potential for illiquid markets. Investing in emerging markets may accentuate these risks.
Fixed income securities are subject to increased loss of principal during periods of rising interest rates. Fixed-income investments are subject to various other risks including changes in credit quality, market valuations, liquidity, prepayments, early redemption, corporate events, tax ramifications and other factors. Lower-rated securities are subject to greater credit risk, default risk, and liquidity risk.